Point72 Asset Management, L.P. - Sep 30, 2025 SCHEDULE 13G/A Report for Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

Filing Manager: Point72 Asset Management, L.P.
Reporting Manager: Point72 Asset Management, L.P.
Security: Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: XLO
Shares outstanding: 80.8M shares
Disclosed Ownership: 8M shares
Ownership: 9.9%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 04:02 PM
Date of event: Sep 30, 2025
Previous filing: Jun 17, 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Point72 Asset Management, L.P.	9.9%	8M	8M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc.	9.9%	8M	8M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person
Steven A. Cohen	9.9%	8M	8M	/s/ Jason M. Colombo	Jason M. Colombo, Authorized Person